Aiforia Technologies, founded in 2013, is a cutting-edge company headquartered in Finland. Specializing in deep learning AI for image analysis, they provide advanced software solutions that leverage artificial intelligence to enhance the efficiency and precision of medical image analysis across various disciplines, including oncology and neuroscience.
The company's slogan, "Translate images into data, discoveries, and diagnoses with deep learning AI for image analysis," encapsulates its mission to empower pathologists and researchers. Aiforia aids in the detection of disease biomarkers, accelerates drug development, and refines cancer diagnostics, effectively transforming healthcare from discovery to diagnosis.
In June 2021, Aiforia secured a €12.60M Series B investment led by PHC Holdings. Their focus on AI-driven innovation places them at the forefront of the convergence of biotechnology and healthcare, appealing to investors seeking opportunities in this rapidly evolving space.